Cell Press Reviews: Cancer Therapeutics provides an overview of key recent advances and open research questions in cancer treatment. With articles written by leading researchers in the field, this publication offers the most up-to-date insights into how genetics influences treatnent decisions and how the immune system can be employed to battle cancer, and describes the current state-of-the-art in drug discovery and targeted treatments. Contributors to this compilation include many prominent researchers in the field, such as: Daniel A. Haber, Director of Massachusetts General Hospital Cancer Center and Professor at Harvard Medical School; Tony Kouzarides, Professor at the University of Cambridge, Deputy Director of the Wellcome Trust/Cancer Research UK Gurdon Institute, and a founder of the cancer drug discovery company Chroma Therapeutics; and Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center, President of the American Association for Cancer Research, member of the presidentially appointed National Cancer Advisory Board, and recipient of the 2013 Breakthrough Prize in Life Sciences.
This book will assist both experts and those new to the field in understanding the current state and future direction of cancer therapy.
- Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved